Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
JFE Holdings forecasts H1 business profit at JPY 90 billion, net profit at JPY 65 billion

JFE Holdings forecasts H1 business profit at JPY 90 billion, net profit at JPY 65 billion

ReutersReuters2026/08/05 05:12
  • JFE Holdings set first-half fiscal 2026 guidance: revenue JPY 2.38 trillion, business profit JPY 90 billion, profit before tax JPY 85 billion.
  • Guidance implies profit attributable to owners of parent of JPY 65 billion, basic EPS JPY 102.18.
  • First-half fiscal 2025 results were revenue JPY 2.23 trillion, business profit JPY 45.77 billion, profit before tax JPY 34.17 billion.
  • Dividend outlook maintained at JPY 80 per share for fiscal 2026, split into interim JPY 40, year-end JPY 40.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. JFE Holdings Inc. published the original content used to generate this news brief on August 05, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Electra Therapeutics (ETRA.US) submits US IPO application, leveraging the biotech IPO boom to advance new drug development for immune diseases and cancer.

Electra Therapeutics Inc. has officially filed for an initial public offering (IPO), aiming to leverage the strong IPO performance of the biotechnology sector this year to raise funds for its clinical-stage pipeline of drugs targeting immune-mediated diseases and cancer.

智通财经2026/08/29 03:22
Electra Therapeutics (ETRA.US) submits US IPO application, leveraging the biotech IPO boom to advance new drug development for immune diseases and cancer.